Newstral
Article
engadget on 2023-01-21 18:56
FTC asks court to hold Martin Shkreli in contempt for launching new drug company
Related news
- MMartin Shkreli faces FTC contempt request in drug casemvtelegraph.com
- FTC: Shkreli may have violated lifetime pharma ban, should be held in contemptArs Technica
- FTC accuses 'Pharma Bro' Martin Shkreli of flouting lifetime ban from industryNew York Post
- ‘Pharma bro’ Martin Shkreli yet to pay $65M fine for lifetime ban: FTCNew York Post
- ‘Pharma Bro’ Shkreli Violated Lifetime Ban And Should Be Sanctioned, FTC SaysForbes
- FTC and Bipartisan State AGs Win Landmark Case Against ‘Pharma Bro’ Martin Shkreli Over Daraprim Monopolyjdsupra.com
- DMartin Shkreli jury asks about assets in Pharma Bro trialDaily News
- Ex-drug CEO Shkreli asks U.S.court to consider blocking subpoenaReuters
- Bankruptcy Court Lets FTC Collect Contempt Fine Despite Bankruptcyjdsupra.com
- Duckworth asks FTC to examine formula marketPOLITICO
- FTC to hold workshop on lead generationjdsupra.com
- TFTC to hold virtual AI summitthehill.com
- Court Puts FTC Noncompete Ban on Holdjdsupra.com
- FTC and FCC to hold robocall forumjdsupra.com
- Facebook asks recusal of FTC head in antitrust case decisionstaradvertiser.com
- FTC asks Twitter for Elon Musk’s internal communications: reportNew York Post
- MSenator asks FTC to revisit Google antitrust casemarketwatch.com
- Facebook asks judge to dismiss FTC antitrust charges... againengadget
- Facebook asks court to dismiss FTC antitrust complaintSeattle Times
- Koster asks court to hold Walgreens in contemptbizjournals.com